Animal and technical models often require repeated anaesthetic administrations for surgical procedures. As there is evidence for immunomodulatory effects of anaesthesia, the effects of repeated exposure to sevo urane anaesthesia on the immune response in mice were studied. Sevo urane was administered in vivo under conditions that simulate those in clinical procedures. Adult male mice were anaesthetized with 3% sevo urane in oxygen for 40 min weekly for 3 weeks. Untreated animals served as controls. After sevo urane anaesthesia, peripheral blood leukocyte counts, the composition and in vitro function of spleen cells (lymphocytes and macrophages) and the in vivo immune response to a conventional T-dependent antigen were assessed. In addition, liver, spleen and kidney histopathology and also hepatic and renal function were studied. Three days after the latest anaesthetic procedure, the absolute number of both leukocyte and lymphocyte counts were reduced in peripheral blood. Splenic cell composition (LB, LTCD3 ‡ , LTCD4 ‡ and LTCD8 ‡ ), macrophage function and the mitogen-induced lymphoprolipherative response were preserved. Yet, the in vivo humoral response to a conventional antigen was augmented following the antigenic challenge. Assessment at day 9 after the last anaesthetic procedure revealed the persistence of the humoral response alteration. Nevertheless, sevo urane-treated animals showed no evidence of histological changes or alteration in hepatic or renal function.
Immunological homeostasis is affected by anaesthesia and surgery (Salo 1992) . Although the most important factor in the postoperative impairment of the immune response is the extent of the operative trauma, anaesthesia by itself can modulate the response to surgery. In experimental models, anaesthetic-induced immune alterations might bias the results to a wide range of physiological research.
Immune alterations occurring after general anaesthesia include changes in natural killer cell activity, T-lymphocyte subpopulations, lymphocyte blastogenic responses and monocyte and neutrophil activity (Salo 1992 , McBride 1996 , Sheeran & Hall 1997 , Desborough 2000 . However, some of these ndings were achieved under experimental conditions such as increased anaesthetic concentration or longer exposure time that did not correlate with those of clinical procedures. The absolute contribution of anaesthetic agents in immunodepression is, however, unclear, and the precise role of anaesthesia in the establishment of perioperative alterations of the immune response (infection, dissemination of malignancy, autoimmunity) is not clearly understood (Moudgil & Singal 1997 , Imai et al. 1998 , Piersma et al. 1999 . Inhalatory anaesthetic may either produce reversible and short-term alterations on cellular functions or cause acute and chronic toxicity as a result of the formation of intermediate and end metabolic compounds (Rice & Fish 1994) . Our group studied the effect of several inhalatory anaesthetics on components of the immune response as well as on their functional activities, both in vivo and in vitro in a mouse model (Puig et al. 1993 (Puig et al. , 1995 . We found an enhancement of the humoral response upon repeated halothane exposure. This effect was mediated by spleen cells and lasted for several days following the anaesthetic treatment.
Given these considerations, it follows that management of anaesthesia, the selection of the anaesthetic agent and its administration method are very important factors in maintaining immune system homeostasis in a research setting.
Sevo urane, a recently licensed anaesthetic for clinical use, has low solubility in blood, enabling precise and rapid changes in anaesthetic depth, as well as fast induction and recovery (Kharasch 1995a,b) . Hence, sevo urane may be useful in animal research where the latter action is required for a better anaesthesia.
Considering that animal experimental models often require repeated anaesthetic treatments for surgical procedures, the aim of the present investigation has been to characterize the effects of repeated exposure to sevo urane anaesthesia on the immune response in mice without surgery. Although most of the anaesthetic dose of sevo urane is probably quickly metabolized after administration, we explored the immunogenic responses of sevo urane-anaesthetized animals to different antigenic stimuli.
Materials and methods

Animals
Experiments were conducted following the Experimental Guidelines for Animal Studies, School of Medicine, National University of Rosario. Seventy to 100-day-old adult male mice, weighing 30-35 g, from a local inbred strain CBi (Centro de BiologẂa, Facultad de Ciencias Mé dicas, UNR, Argentina) were used. The strain derives from BALB=c mice, and animals have been inbred since 1968, making its average inbreeding coef cient approximately 0.95.
Animals were quarantined for 15 days, and it was con rmed that they were free of a variety of pathogens, including ecto-and endoparasites, mycoplasms and pasteurellae, lymphocytic choriomenigitis virus, mouse hepatitis virus, Hantaan virus and mouse pneumonitis virus.
Animals were kept in conventional conditions (open system) and housed in groups of six animals in plastic cages ( oor area 800 cm 2 , height 14 cm) on sterilized wood chip bedding. They were provided with standard 8 mm pelleted mouse-rat diet (Cargill, Argentina) and water ad libitum, before and after the anaesthetic procedure. All experiments were conducted at 08.30 h. Room temperature and humidity were maintained at 21 § 2¯C and 50-70%, respectively, with 10 air changes per hour. Fluorescent lighting was provided with a 12 h light (07:00 to 19:00) and 12 h dark photoperiod. All experimental groups shared the same environmental conditions. Food intake and body weight were recorded before and during the study.
Anaesthetic method
Sevo urane ( uoromethyl 2-2 di uoro 1-tri uoromethyl vinyl ether, Sevorane, Abbot-Argentina) was delivered by a thermocompensated vaporizer (Blease Datum, Cheshand, UK) at 3% (1,2 MAC, Egers et al. 1965) , and vaporized at atmospheric pressure in oxygen at 6 l=min ow. Groups of six animals were anaesthetized for 40 min in a continuous ow chamber, breathing spontaneously without any surgical manoeuvres. This anaesthetic procedure was performed at weekly intervals for 3 weeks. The anaesthetic concentration used in the present work produced immobility in 99% of exposed mice to a standardized noxious stimulus, namely clamping the tail (Egers et al. 1965) .
Animals placed in an induction box and subjected to the same manipulations of treated mice except for anaesthesia were used as controls.
Experimental design
Sixty animals were allocated at random to one of the following groups:°S evo urane: anaesthetized as previously described°C ontrol: age-matched animals Twelve animals from each group were used for the immune response and toxicity studies. Moreover, two additional groups of 18 animals each (nˆ6 for each time point evaluation) were used for the analysis of sevo urane exposure effects on the in vivo primary immune response.
Euthanasia
As our study involved the ex vivo assessment of cellular functions (phagocytosis, proliferation and secretion of antibodies) and the evaluation of histological changes in spleen, liver and kidney, we selected the most appropriate means of euthanasia. Our group followed the report of the AVMA panel on euthanasia (Beaver et al. 2001) , the recommendations for euthanasia of experimental animals (Close et al. 1996 (Close et al. , 1997 and the guidelines established for animals use in toxicity evaluation (Lukas 1994) . Therefore, several alternatives were considered. Sodium pentobarbital injection was not appropriate because it causes congestive splenomegaly and leaves tissue residues. Carbon dioxide inhalation, used commonly for rodents, does not leave tissue residues but causes cellular changes associated with hypoxemia. Cervical dislocation was then chosen because it is the least likely to affect the immune system. It induces rapid loss of consciousness, as a physical method it does not leave tissue residues, and it is rapidly accomplished, safe and effective. Cervical dislocation was performed by a properly trained technician. This choice was approved by the Ethic Committee for Animal Care and Use, School of Medicine, National University of Rosario.
Immune response parameters
Immune response parameters were assessed 3 days after the third sevo urane administration. Mice were killed by cervical dislocation and blood samples were immediately obtained by heart puncture. Blood samples were assessed for erythrocyte counts as well as total and differential leukocyte counts, which were measured by standard clinical laboratory procedures (Hunt 1987) . The automated analysis (Cell-dyn 1700-CS, Abbot Laboratories, USA) was complemented by microscopic evaluation of the respective blood smear.
Preparation of spleen cells
Mice were killed 3 days after the third anaesthetic procedure by cervical dislocation. The spleens were removed and cells were collected in a Petri dish containing Hank's balanced salt solution (HBSS, Sigma, St Louis, USA) at pH 7.3, for immunoglobulin secreting cells (Ig-SC) quantitation, or in RPMI 1640 (Gibco, Grand Island BRL, USA) for cytouorometric tests and mitogenic responses. Spleen mononuclear cells were isolated by the Ficoll-Hypaque gradient centrifugation method. Viability was assessed by the trypan blue dye exclusion test (Hunt 1987) .
Quantitation of splenic T-and B-cell subpopulations
Surface phenotype of cells was identi ed by using antibodies coupled with uorescein isothiocyanate (FITC) or phycoerythrin (PE), in conjunction with a two-colour immunouorescence test. The monoclonal reagents were 20 ml of a 10 mg=ml solution of PEconjugated anti-mouse CD3-e (Boehringer Mannheim, USA), 20 ml of a 10 mg=ml solution of FITC-conjugated anti-mouse CD4 (anti-L3T4 Boehringer Mannheim, USA), or 5 ml of anti-CD8-FITC 10 mg=ml (anti-Ly-2 Becton Dickinson, USA). To identify B-cells, 5 ml of a 10 mg=ml solution of anti Ig-FITC (Sigma, St Louis, USA) was used. The antibodies were diluted in phosphate buffered saline, which contained 0.1% sodium azide and 0.1% bovine serum albumin. Optimal antibody dilution was determined empirically. Brie y, 20 ml of spleen cell suspension containing 5610 4 cells were incubated for 20 min at 4¯C with speci c antibodies at the appropriate dilution in RPMI 1640 (Gibco, Grand Island BRL, USA), without phenol red, supplemented with 3% decomplemented fetal calf serum (FCS, Gibco, Grand Island BRL, USA) and washed twice. Cells were xed in 4% w=v paraformaldehyde in 50 mmol=l sodium= potassium phosphate buffer pH 7.2. Fluorescence-positive cells were recorded by FACScan (Becton Dickinson & Co, USA) ow cytometer, after being washed with RPMI. In each sample a minimum of 10 4 cells was analysed. CD4 ‡ , CD8 ‡ and B ‡ cells were calculated as a percentage above a threshold de ned by matched isotype (rat IgG 2a ) control (Mason et al. 1987) .
Lymphocyte proliferation assay
Spleen cells were resuspended in RPMI 1640 containing standard concentrations of Lglutamine (300 mg=ml), penicillin (100 units per ml), streptomycin (100 mg=ml), HEPES (25 mM) (Gibco, Grand Island BRL, USA), 1610 ¡ 5 M 2-mercaptoethanol and 10% FCS. Cultures were set in quadruplicate in atbottomed microculture plates. Each well contained 100 ml of cell suspension (2610 5 cells=well) plus 100 ml concanavalin A (Con A Sigma, St Louis, USA), pokeweed (PWM Sigma, St Louis, USA) or E. coli lipopolysaccharide (LPS Sigma, St Louis, USA). Con A, LPS and PWM were used at a nal concentration of 0.62, 1.25, 2.5 and 5 mg=ml. The cells were cultured for 3 days and pulsed with 1 mCi of 3 H-thymidine (New England Nuclear NET-027E) per well, 18 h before harvesting into glass bre lters with a manual Nunc Cell Harvester 8. Incorporation of 3 Hthymidine was measured by using a liquid scintillation counter (Rack Beta Counter LKB, Sweden). Results were expressed as the stimulation index (SI) which represents the ratio of the mean incorporation of 3 H-thymidine in the test wells to that containing non-stimulated cells (Knight 1987) .
Evaluation of the phagocytic and lytic function of monocytes against Candida pseudotropicalis
The method was performed following an adaptation of the technique of Ballart et al. (1987) . Brie y, adherent cell monolayers were prepared in 6-well at-bottomed plates with glass coverslips by adding 3610 6 spleen cells in RPMI 1640 (Gibco, Grand Island BRL, USA) media, 1610 ¡ 5 M 2-mercaptoethanol and 20% FCS (Gibco, Grand Island BRL, USA). The plates were cultured for 24 h at 37¯C, and then washed twice with 199 medium (Grand Island Biological Co, NY, USA). One ml containing 3610 6 opsonized C. pseudotropicalis was added to each well and the cell mixture was incubated at 37¯C for 30 min, and then washed three times with warm medium. To evaluate the phagocytic and litic function of monocytes against C. pseudotropicalis, coverslip monolayers were examined for morphology under light microscopy after Giemsa counterstaining.
The number of phagocytic cells per 100 adherent cells, the number of C. pseudotropicalis ingested per 100 macrophages and the percentage of ghost images (dead yeast cells) per 100 ingested C. pseudotropicalis were recorded under blind conditions. Cultures were set in triplicate, and 500 adherent cells were examined.
Effect of sevo urane exposure on the in vivo primary immune response
Experimental groups were (1) Sevo urane group: anaesthetized with sevo urane, as previously described, and 3 days later immunized with sheep red blood cell (SRBC), (2) Control group: mice subjected to the same manipulations except for anaesthesia, and further immunized with SRBC. Both groups received an antigenic challenge of 0.1 ml of SRBC, washed and resuspended at 25% in phosphate buffered saline, intraperitoneally (i.p.).
The number of speci c anti-SRBC immunoglobulin secreting spleen cells (Ig-SC) was determined in six animals from each group on days 4, 5 and 6 after the SRBC stimulus, as the response is maximal during these days in our system.
The number of Ig-SC was assessed by the indirect haemolytic plaque assay (Cunningham & Szenberg 1968) . Both IgM and IgG SC were recorded by this technique. Brie y, 100 ml of a mixture containing 10 5 immune spleen cells, 100 ml of 10% SRBC, 20 ml of 10% guineapig serum in HBSS (Sigma, St Louis, USA) as a source of complement, and 20 ml of 1:200 rabbit anti-mice IgG (Sigma, St Louis, USA) were loaded into duplicate Cunningham chambers (Spiral Scienti c, Cincinatti, USA) and placed at 37¯C. An hour later, the number of cells surrounded by haemolytic plaques (Ig-SC) was counted by light microscopy at low magni cation. Data were expressed as the number Ig-SC=10 6 spleen cells. The total number of Ig-SC=spleen was also calculated.
Toxicological parameters
Histological studies Following recommended procedures (Smialowicz 1995) , histopathological studies were performed in mice after repeated sevo urane administration to exclude forms of toxicity which may have some repercussion on the host immune responsiveness.
Mice were weighed before the study. Three days after the last anaesthetic exposure, mice were killed by cervical dislocation and the organ=body weight ratios for the spleen, liver and kidney were determined. Data are expressed as a percentage of body weight.
Liver, spleen, thymus, kidney, and the right inguinal lymph node were removed, transversally sliced, and xed in neutral formalin. Paraf n-embedded 5 mm sections were stained with haematoxylin and eosin. Two whole serial sections per organ were examined. Data were interpreted by a pathologist blinded to the study groups.
As drug-induced toxic effects can result in hepatic fatty changes, two sections of one hepatic lobe from six animals=group were studied. Frozen liver sections were prepared and stained with Oil Red-O to con rm the fat content of vacuoles (Pearse 1960) .
Parameters of hepatic and renal function Parameters of hepatic and renal function were evaluated in serum samples collected by cardiac puncture 3 days after the last sevo urane anaesthesia. Serum parameters of hepatic function: aspartate aminotransferase (GOT=AST), alanine aminotransferase (GPT=ALT), alkaline phosphatase and pseudocholinesterase were determined by kinetic reactions (reagents were kindly gifted by Wiener lab, Rosario, Argentina) with measurements being performed in a Vitalab Selectra 2 (Vital Scienti c, The Netherlands). Renal parameters (urea and creatinine) were determined by colorimetric methods with the same reagent supplier and equipment.
Statistical analysis
Statistical differences among groups were calculated by the Student's t-test. Whenever we were unsure of the normal distribution of data, differences between groups were evaluated by the Mann-Whitney U-test. An associated probability lower than 0.05 was considered signi cant.
Results
Administration of 100% oxygen, or sevourane 3% in oxygen did not alter mice body weight or food intake following treatment. Regarding the effect of repeated sevo urane exposure on peripheral blood, there were no differences between control and anaesthetized mice in the number of erythrocytes and neutrophils, although leukocytes and lymphocytes were diminished 3 days after the last anaesthesia (P < 0.025 and P < 0.01, respectively) ( Table 1) .
The anaesthetic treatment did not affect white cell counts or lymphocyte composition of the spleen. There were no differences in the number of B-cells, or T-cell CD4 ‡ and CD8 ‡ subpopulations. In addition, the CD4 ‡ :CD8 ‡ ratio of treated mice remained unaltered (Table 1) .
When the activity of splenic monocytes against C. pseudotropicalis was studied in six animals of each group, no differences were found in the number of phagocytic cells per 100 adherent cells (median-rank: control: 72.3-15.4 vs sevo urane: 69-7.3) or in the number of ingested yeast (control: 316-50 vs sevo urane: 270-56). Furthermore, sevo urane treatment did not affect the capacity to kill the ingested C. pseudotropicalis (control: 8.7-5.7 vs sevo urane: 8.53-2.58). Spleen cells from treated mice achieved an adequate mitogenic response to different doses of Con A, LPS and PWM, and did not differ from control mice (Fig 1) .
To evaluate the effect of sevo urane on the in vivo humoral immune response, SRBC were given 3 days after the last anaesthetic treatment. In treated mice, the number of speci c immunoglobulin secreting spleen cells (Ig-SC) was increased 5 and 6 days after the antigenic challenge, re ected in a signi cantly higher peak number of splenic Ig-SC than in control mice (Fig 2) .
When studying the potential toxic effect of sevo urane, there was a signi cant increase in the relative weight of the kidney upon repeated exposure to sevo urane, while there were no changes in the relative weight of the liver and spleen (Table 2) . Histological studies showed no evidence of organ injury. The architecture of the spleen, thymus, lymph node, liver and kidney was conserved. Regarding the spleen, 3 days after the anaesthetic treatment there were no differences either in the red pulp=white pulp ratio or in its cellularity. The number and size of germinal centres did not differ in treated and control animals. In addition, microscopic studies did not reveal differential fatty changes in the liver between control and anaesthetized animals (data not shown).
Laboratory serum markers of hepatic (GOT, GPT, alkaline phosphatase and pseudocholinesterase) and renal function (urea and creatinine) were not signi cantly different between control and treated mice, indicating no alterations due to sevo urane anaesthesia.
Discussion
This study has investigated the effect of multiple sevo urane administrations on several components of the immune response in mice. Three days after the latest anaesthetic administration, sevo urane modulated the immune response in mice, diminishing the absolute number of both leukocytes and lymphocytes in peripheral blood. The splenic cell composition, the function of macrophages and mitogeninduced lymphoprolipherative responses were preserved. In contrast, the in vivo humoral response to a conventional antigen was augmented in treated animals. Sevo urane-treated animals showed only a marginal increase in the relative weight of the kidney, with no evidence of histological changes or hepatic or renal functional alterations.
The decrease in leukocyte counts has been previously reported in animals during anaesthesia, whereas anaesthesia and surgery produced leukocytosis, with no changes in the absolute number of lymphocytes during minor or moderate surgery (Moudgil 1992 , Salo 1992 , Morisaki et al. 1998 , Mattila-Vuori et al. 1999 . Immune cell traf cking is crucial for immunological surveillance and effector functions. The number and proportion of leukocytes in the circulation are informative regarding the leukocyte distribution. Anaesthesia and surgery might in uence lymphocyte numbers, the relative composition of lymphocyte subpopulations, and their proliferative pro le. These changes might be attributed to different mechanisms. Firstly, adrenal hormones released as the result of stress may signal speci c leukocytes to leave the peripheral blood and enter other compartments, such as lymph nodes, Peyer's patches, bone marrow, lung, skin and mucosal tissues, which serve as 'battle' or 'communication stations' (Dhabhar et al. 1995) . Moreover, some evidence suggests that the sympathetic innervation associated with lymph nodes and Peyer's patches vasculature, as well as active neuropeptides, i.e. the vasoactive intestinal neuropeptide, might modulate the in vivo lymphocyte migration, leading to rapid changes in lymphocyte subpopulations in these organs (Ottaway & Husband 1994) . Finally, sevo urane anaesthesia alone has been reported to mediate such effects (Pagel et al. 2000) . In this respect, Morisaki et al. (1997 Morisaki et al. ( , 1998 communicated that sevo urane modi ed microcirculation by affecting leukocyte transvasation to tissues. Surgical concentrations of sevo urane (2 MAC) induced leukocyte rolling and adhesion to microvascular endothelium in the rat mesentery via endothelial cell-dependent mechanisms. Leukocyte adhesion was fully reversed 20 min after decreasing sevo urane concentration to 1 MAC. Contrastingly, in the present work we found leukopenia 3 days after the last 1.2 MAC sevo urane administration.
We further evaluated the number and function of cells involved in the immune response. As the spleen is the relevant lymph organ involved in immunity against antigens entering the intraperitoneal route, and it was shown in earlier studies that spleen cells transfer the halothane-enhancing effect (Puig et al. 1993) , we characterized the splenic composition of immunocompetent cells as well as their functional activities. No differences in splenic white cell counts were observed. Repeated sevo urane exposure did not affect the percentage of the main lymphocyte subpopulations:
When the activity of monocytes was studied, we found no differences in the number of phagocytic cells or in the monocyte avidity for yeast. Moreover, the treatment did not affect the capacity to kill the ingested Candida.
Another key reaction regarding the immune response, lymphoproliferation, was not affected by sevo urane. The blastogenic response of splenic cells following stimulation with mitogens testing T (Con A), B (LPS) and B-T-dependent (PWM) responses was preserved in treated animals.
The assessment of the speci c antibody production to a T-dependent antigen as SRBC is a reliable tool for evaluating immunomodulation (Luzzatti et al. 1995) . The present study has established that repeated sevourane exposure enhances the in vivo SRBC immune response. Moreover, previous results have indicated that a single sevo urane exposure enhances the response to SRBC (Puig et al. 2002) , while multiple halothane exposures are required to induce similar effects (Puig et al. 1993 (Puig et al. , 1995 . Salo et al. (1997) , as well, observed an increased number of Ig secreting cells in surgical patients 7 days after anaesthesia. In contrast, Lockwood (1993) showed that neither halothane nor methoxy urane anaesthesia alter antibody levels when the animals are immunized intraperitoneally with keyhole limpet haemocyanin 1 or 3 weeks after the exposure to anaesthesia in a rat model. It follows then, that differences in the timing of the antigenic challenge, or in the nature of the antigen or in the evaluated species may be involved in the reported features of anaesthetic-mediated immnomodulatory effects.
We also evaluated the hepatic and renal function. Results showed that 3 days after the last sevo urane exposure, macroscopic and microscopic examination of the spleen, thymus, lymph node, liver and kidney examination showed no differences between control and anaesthetized groups, consistent with the low biotransformation rate of sevo urane (Kharasch et al. 1995a ). In line with these ndings, there were no differences in post-anaesthetic liver function evaluated by routine clinical laboratory tests. Liver function after inhalation anaesthesia depends on the liver blood ow during anaesthesia, the increased intracellular calcium concentration, and anaesthetic biotransformation. It is also in uenced by other drugs used perioperatively (Baker & Van Dyke 1994) . Sevo urane is commonly thought to be less hepatotoxic than halothane and en urane although, recently, liver dysfunction has been reported after sevourane anaesthesia (Kharasch et al. 1995a , Soma et al. 1995 .
Renal function after inhalation anaesthesia depends on systemic haemodynamics, renal blood ow, renal blood ow distribution and tubular sensitivity to uoride (Fish 1994) . After sevo urane anaesthesia there was a marginal increase in the relative weight of kidney. Nevertheless, we cannot point out a potentially causal relationship for the augmented kidney weight in treated animals. Yet our ndings showed neither histopathological alterations nor differences in renal function evaluated by relevant pathophysiological markers, as urea and creatinine plasma concentration (Basketter et al. 1995) . Furthermore, there is no evidence of sevourane-nephrotoxic effects in mouse or rat models (Frink et al. 1992 , Malan et al. 1993 .
Additional evidence, supporting that a repeated exposure to sevo urane does not affect hepatic and renal functions, was provided by parallel groups of treated mice evaluated on days 5, 7, and 10 following anaesthesia. They also showed no histopathological alterations or changes in functional hepatic and renal parameters due to the anaesthetic treatment (unpublished results).
In previous papers our group found that halothane anaesthesia caused increases in speci c antibody levels and antibodysecreting cells, together with diminished CD4 ‡ , CD8 ‡ and B-cell numbers in the spleen. Both lymphoproliferation and delayed type hypersensitivity reactions were conserved in halothane-treated animals. As regards toxicity, halothane-treated animals showed microscopic evidence of hepatotoxicity with diffuse metamorphosis, and diminished lipid peroxidation (Elena et al. 1997 , Puig et al. 1999 . Based on present results and our experience on single sevo urane anaesthesia (Puig et al. 2002) we conclude that sevo urane is more innocuous to the immune system than halothane together.
According to our studies, it can be concluded that sevo urane was responsible for the immune response modulation because our mice were highly inbred, they shared the same environmental conditions and were randomly allocated to treatment. As the sevo urane-associated immunological changes lasted several days, it remains to be established whether such an effect may become detrimental. Our results indicate that sevo urane is a safe anaesthetic for the mouse, even upon repeated exposure. However, assessing the eventual effects of anaesthesia on immunological studies is recommended.
